CDH2 and neoplasm: In a prospective trial of 30 surgically treated NSCLC patients, CTC and matched tumor tissue expression of PD-L1 and EMT markers vimentin and N-Cadherin was compared, and CTC phenotypes correlated with survival after curative treatment of NSCLC patients.